Idor­sia sells off Asian op­er­a­tions, top drug li­cens­es to So­sei Hep­tares in $465M deal

Last year
Deals

Spe­cial re­port 2023: Meet 20 women re­shap­ing bio­phar­ma

Last year
Special

Affi­ni-T to close Seat­tle lab as it con­cen­trates in Boston, preps two IND fil­ings in next two months

Last year
People
Startups

A small Swiss biotech tack­les a huge glob­al health is­sue with a hand­off from GSK. But can it make any mon­ey from it?

Last year
Deals
Bioregnum

An­titrust en­forcers roll out draft guide­lines amid crack­down on phar­ma­ceu­ti­cal merg­ers

Last year
Deals

Tik­Tok takes down ac­counts for weight loss in­flu­encers who dis­cussed We­govy, Moun­jaro

Last year
Pharma
Marketing

SEC fines for­mer Mer­ck ex­ec over in­sid­er trad­ing al­le­ga­tions

Last year
Pharma
Law

WHO sounds the alarm over more con­t­a­m­i­nat­ed cough syrup in Africa

Last year
Pharma
Manufacturing

Eu­ro­pean Com­mis­sion re­jects Ipsen's ul­tra-rare dis­ease drug af­ter two neg­a­tive opin­ions from EMA

Last year
Pharma

Stan­ford pres­i­dent re­signs fol­low­ing sci­en­tif­ic mis­con­duct in­ves­ti­ga­tion

Last year
People

Biotech’s op­ti­mism is re­turn­ing amid signs of a bet­ter sec­ond half and a brighter 2024

Last year
Financing
Startups

Gink­go Bioworks hand­ed a DARPA man­u­fac­tur­ing con­tract; Mer­ck hits a pri­ma­ry end­point for Keytru­da in first-line ...

Last year
News Briefing

Har­row prices $60M of­fer­ing one day af­ter ac­quir­ing US, Cana­di­an rights to new dry eye treat­ment

Last year
Financing

Af­ter mul­ti­ple clin­i­cal tri­al fail­ures, Fi­bro­Gen lays off one-third of staff

Last year
People

ARCH-backed Im­muneID re­struc­tures and search­es for part­ners

Last year
People
Startups

Im­munother­a­py dur­ing surgery? Surge Ther­a­peu­tics nabs $32M to ex­pand clin­i­cal plans af­ter first dos­ing

Last year
Financing

Amarin lays off US sales­force, names new CEO in shake­up

Last year
R&D

Rid­ing on pos­i­tive da­ta, ar­genx rais­es $1.1B while Alzheimer's biotech Acu­men lands $130M

Last year
Financing

Doc­tors with­out Bor­ders asks J&J not to en­force sec­ondary patents for TB drug af­ter gener­ic deal with non­prof­it

Last year
Deals
Pharma

Strate­giz­ing a new drug launch? Don’t over­look soft skills for sales reps, whitepa­per says

Last year
Pharma
Marketing

House Re­pub­li­cans ques­tion FDA's progress on phar­ma in­spec­tions in In­dia and Chi­na

Last year
FDA+
Manufacturing

CMS pro­pos­es new cov­er­age pol­i­cy for Alzheimer's-re­lat­ed PET scans

Last year
Pharma
FDA+

In­gre­di­ent man­u­fac­tur­er Cen­taur gets FDA warn­ing over records, sub­stan­dard clean­ing

Last year
Pharma
FDA+

Pieris Phar­ma­ceu­ti­cals lays off 70% of work­force af­ter As­traZeneca ends asth­ma med­i­cine part­ner­ship

Last year
People
Pharma
First page Previous page 309310311312313314315 Next page Last page
A service from the Financial Times